Eintrag weiter verarbeiten
Online-Ressource

Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC stu...

Gespeichert in:

Bibliographische Detailangaben
Zeitschriftentitel: BMJ Open Gastroenterology
Personen und Körperschaften: Sheridan, Juliette, Coe, Carol Ann, Doran, Peter, Egan, Laurence, Cullen, Garret, Kevans, David, Leyden, Jan, Galligan, Marie, O’Toole, Aoibhlinn, McCarthy, Jane, Doherty, Glen
In: BMJ Open Gastroenterology, 5, 2018, 1, S. e000174
Format: E-Article
Sprache: Englisch
veröffentlicht:
BMJ
Schlagwörter:
Gastroenterology
author_facet Sheridan, Juliette
Coe, Carol Ann
Doran, Peter
Egan, Laurence
Cullen, Garret
Kevans, David
Leyden, Jan
Galligan, Marie
O’Toole, Aoibhlinn
McCarthy, Jane
Doherty, Glen
Sheridan, Juliette
Coe, Carol Ann
Doran, Peter
Egan, Laurence
Cullen, Garret
Kevans, David
Leyden, Jan
Galligan, Marie
O’Toole, Aoibhlinn
McCarthy, Jane
Doherty, Glen
author Sheridan, Juliette
Coe, Carol Ann
Doran, Peter
Egan, Laurence
Cullen, Garret
Kevans, David
Leyden, Jan
Galligan, Marie
O’Toole, Aoibhlinn
McCarthy, Jane
Doherty, Glen
spellingShingle Sheridan, Juliette
Coe, Carol Ann
Doran, Peter
Egan, Laurence
Cullen, Garret
Kevans, David
Leyden, Jan
Galligan, Marie
O’Toole, Aoibhlinn
McCarthy, Jane
Doherty, Glen
BMJ Open Gastroenterology
Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)
Gastroenterology
author_sort sheridan, juliette
spelling Sheridan, Juliette Coe, Carol Ann Doran, Peter Egan, Laurence Cullen, Garret Kevans, David Leyden, Jan Galligan, Marie O’Toole, Aoibhlinn McCarthy, Jane Doherty, Glen 2054-4774 BMJ Gastroenterology http://dx.doi.org/10.1136/bmjgast-2017-000174 Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772) BMJ Open Gastroenterology
doi_str_mv 10.1136/bmjgast-2017-000174
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEzNi9ibWpnYXN0LTIwMTctMDAwMTc0
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEzNi9ibWpnYXN0LTIwMTctMDAwMTc0
institution DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
imprint BMJ, 2018
imprint_str_mv BMJ, 2018
issn 2054-4774
issn_str_mv 2054-4774
language English
mega_collection BMJ (CrossRef)
match_str sheridan2018protocolforamulticentredrandomisedcontrolledtrialinvestigatingtheuseofpersonalisedgolimumabdosingtailoredtoinflammatoryloadinulcerativecolitisthegoalarcstudyglmdoseoptimisationtoadequatelevelstoachieveresponseincolitisledbytheinitiativegroupnct0268772
publishDateSort 2018
publisher BMJ
recordtype ai
record_format ai
series BMJ Open Gastroenterology
source_id 49
title Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)
title_unstemmed Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)
title_full Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)
title_fullStr Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)
title_full_unstemmed Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)
title_short Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)
title_sort protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the goal-arc study (glm dose optimisation to adequate levels to achieve response in colitis) led by the initiative group (nct 0268772)
topic Gastroenterology
url http://dx.doi.org/10.1136/bmjgast-2017-000174
publishDate 2018
physical e000174
description
container_issue 1
container_start_page 0
container_title BMJ Open Gastroenterology
container_volume 5
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792341125372051456
geogr_code not assigned
last_indexed 2024-03-01T16:14:57.301Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Protocol+for+a+multicentred+randomised+controlled+trial+investigating+the+use+of+personalised+golimumab+dosing+tailored+to+inflammatory+load+in+ulcerative+colitis%3A+the+GOAL-ARC+study+%28GLM+dose+Optimisation+to+Adequate+Levels+to+Achieve+Response+in+Colitis%29+led+by+the+INITIAtive+group+%28NCT+0268772%29&rft.date=2018-01-01&genre=article&issn=2054-4774&volume=5&issue=1&pages=e000174&jtitle=BMJ+Open+Gastroenterology&atitle=Protocol+for+a+multicentred+randomised+controlled+trial+investigating+the+use+of+personalised+golimumab+dosing+tailored+to+inflammatory+load+in+ulcerative+colitis%3A+the+GOAL-ARC+study+%28GLM+dose+Optimisation+to+Adequate+Levels+to+Achieve+Response+in+Colitis%29+led+by+the+INITIAtive+group+%28NCT+0268772%29&aulast=Doherty&aufirst=Glen&rft_id=info%3Adoi%2F10.1136%2Fbmjgast-2017-000174&rft.language%5B0%5D=eng
SOLR
_version_ 1792341125372051456
author Sheridan, Juliette, Coe, Carol Ann, Doran, Peter, Egan, Laurence, Cullen, Garret, Kevans, David, Leyden, Jan, Galligan, Marie, O’Toole, Aoibhlinn, McCarthy, Jane, Doherty, Glen
author_facet Sheridan, Juliette, Coe, Carol Ann, Doran, Peter, Egan, Laurence, Cullen, Garret, Kevans, David, Leyden, Jan, Galligan, Marie, O’Toole, Aoibhlinn, McCarthy, Jane, Doherty, Glen, Sheridan, Juliette, Coe, Carol Ann, Doran, Peter, Egan, Laurence, Cullen, Garret, Kevans, David, Leyden, Jan, Galligan, Marie, O’Toole, Aoibhlinn, McCarthy, Jane, Doherty, Glen
author_sort sheridan, juliette
container_issue 1
container_start_page 0
container_title BMJ Open Gastroenterology
container_volume 5
description
doi_str_mv 10.1136/bmjgast-2017-000174
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEzNi9ibWpnYXN0LTIwMTctMDAwMTc0
imprint BMJ, 2018
imprint_str_mv BMJ, 2018
institution DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3
issn 2054-4774
issn_str_mv 2054-4774
language English
last_indexed 2024-03-01T16:14:57.301Z
match_str sheridan2018protocolforamulticentredrandomisedcontrolledtrialinvestigatingtheuseofpersonalisedgolimumabdosingtailoredtoinflammatoryloadinulcerativecolitisthegoalarcstudyglmdoseoptimisationtoadequatelevelstoachieveresponseincolitisledbytheinitiativegroupnct0268772
mega_collection BMJ (CrossRef)
physical e000174
publishDate 2018
publishDateSort 2018
publisher BMJ
record_format ai
recordtype ai
series BMJ Open Gastroenterology
source_id 49
spelling Sheridan, Juliette Coe, Carol Ann Doran, Peter Egan, Laurence Cullen, Garret Kevans, David Leyden, Jan Galligan, Marie O’Toole, Aoibhlinn McCarthy, Jane Doherty, Glen 2054-4774 BMJ Gastroenterology http://dx.doi.org/10.1136/bmjgast-2017-000174 Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772) BMJ Open Gastroenterology
spellingShingle Sheridan, Juliette, Coe, Carol Ann, Doran, Peter, Egan, Laurence, Cullen, Garret, Kevans, David, Leyden, Jan, Galligan, Marie, O’Toole, Aoibhlinn, McCarthy, Jane, Doherty, Glen, BMJ Open Gastroenterology, Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772), Gastroenterology
title Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)
title_full Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)
title_fullStr Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)
title_full_unstemmed Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)
title_short Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)
title_sort protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the goal-arc study (glm dose optimisation to adequate levels to achieve response in colitis) led by the initiative group (nct 0268772)
title_unstemmed Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772)
topic Gastroenterology
url http://dx.doi.org/10.1136/bmjgast-2017-000174